Abacus MedicineAbout usNews and Stories

News and Stories

Dive into news and background on Abacus Medicine.

16 September 2019
Investment concluded successfully

Chr. Augustinus Fabrikker invests EUR 48 million to acquire an ownership stake of just over one third of the shares

READ MORE »
02 September 2019
New investment in Abacus Medicine

Abacus Medicine welcomes investment company Chr. Augustinus Fabrikker as strategic shareholder

READ MORE »
29 May 2019
Abacus Medicine postpones IPO

Abacus Medicine decided today to postpone the planned Initial Public Offering (IPO) due to the currently unfavourable market conditions.

READ MORE »
03 May 2019
CSR report 2018

Abacus Medicine adopted a new CSR Policy for 2018 and publishes a CSR Report for the first time this year.

READ MORE »
03 May 2019
Annual Report 2018

Our best year ever. Revenue rose by 31% and Adjusted EBITDA by 39%.

READ MORE »
14 February 2019
FMD is in effect

After the first 6 days, we are very satisfied with our production setup and IT infrastructure.

READ MORE »
24 January 2019
Strategic alliance with Pluripharm

Abacus Medicine extends cooperation with pharmaceutical wholesaler Pluripharm Group

READ MORE »
07 December 2018
New production site in NL

New site will offer daily flexibility and provide a contingency solution

READ MORE »
29 November 2018
New Managing Director for Aposave

Simon Estcourt to head global activities for Aposave, the Abacus Medicine group’s pharmaceutical services company

READ MORE »
01 November 2018
IPO 2018

In October 2018, Abacus Medicine announced and later postponed an Initial Public Offering (IPO) on the Frankfurt Stock Exchange.

READ MORE »